Cancer
Symbiotic-GI-13
Liver Cancer
An Interventional Open-label Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma
Contact Research Team:
[email protected]
Site principal investigator:
Osama MoSalem, MD
Learn more about this study:
NCT07227012